COMPARATIVE TREATMENT OF ACNE VULGARIS USING PALOMAR LUX APPLIQU′E TECHNIQUE AND DIRECT INTRALESIONAL INJECTION

ELINA A. GENINA; ALEXEY N. BASHKATOV; VALERY V. TUCHIN; GEORGY V. SIMONENKO; VERA N. SHERSTNEVA; ILYA V. YAROSLAVSKY; GREGORY B. ALTSHULER

[1] J. J. Leyden, “Acne vulgaris is a multifactorial disease,” J. Am. Acad. Dermatol. 49, S199 (2003).

[2] M. M. Mulder, V. Sigurdsson, E. J. van Zuuren et al., “Psychosocial impact of acne vulgaris. Evaluation of the relation between a change in clinical acne severity and psychosocial state,” Dermatology 203, 124–130 (2001).

[3] C. G. Burkhart, C. N. Burkhart, P. F. Lehmann, “Acne: A review of immunologic and microbiologic factors,” Postgraduate Medical J. 75(884), 328–331 (1999).

[4] W. J. Cunliffe, Acne, Martin Dunitz, Year Book Medical Publishers, Chicago (1989).

[5] Y. Loveˇckov′a, I. Havl′ kov′a, “A microbiological approach to acne vulgaris,” Biomed. Papers 146(2), 29–32 (2002).

[6] D. M. Thiboutot, “Endocrinological evaluation and hormonal therapy for women with difficult acne,” JEADV 15, 57–61 (2001).

[7] J. Verbov, “The place of intralesional steroid therapy in dermatology,” Br. J. Dermatol. 94(suppl. 12), 51–58 (1976).

[8] B. B. Mahajan, G. Gard, “Therapeutic efficacy of intralesional triamcinolone acetonide versus intralesional triamcinolone acetonide plus lincomycin in the treatment of nodulocystic acne,” Indian J. Dermatol., Venereol. Leprol. 69(3), 217–219 (2003).

[9] R. M. Levine, J. E. Rasmussen, “Intralesional corticosteroids in the treatment of nodulocystic acne,” Arch. Dermatol. 119(6), 480–481 (1983).

[10] B. Kjeldstad, A. Johnsson, “An action spectrum for blue and near ultraviolet inactivation of propionibacterium acnes; with emphasis on a possible porphyrin photosensitization,” Photochem. Photobiol. 43, 67–70 (1986).

[11] V. Sigurdsson, A. C. Knulst, H. van Weelden, “Phototherapy of acne vulgaris with visible light,” Dermatology 194, 256–260 (1997).

[12] P. Papageorgiou, A. Katsambas, A. Chu, “Phototherapy with blue (415 nm) and red (660 nm) light in the treatment of acne vulgaris,” Br. J. Dermatol. 142, 973–978 (2000).

[13] W. J. Cunliffe, V. Goulden, “Phototherapy and acne vulgaris,” Br. J. Dermatol. 142, 853–856 (2000).

[14] W. Hongcharu, C. R. Taylor, Y. Chang, D. Aghassi, K. Suthamjariya, R. R. Anderson, “Topical ALAphotodynamic therapy for the treatment of acne vulgaris,” J. Invest. Dermatol. 115, 183–192 (2000).

[15] K. Koenig, H. Meyer, “Photodynamic activity of methylene blue,” Akt. Dermatol. 19, 195–198 (1993).

[16] E. A. Genina, A. N. Bashkatov, G. V. Simonenko, O. D. Odoevskaya, V. V. Tuchin, G. B. Altshuler, “Low-intensity Indocyanine green — laser phototherapy of acne vulgaris: Pilot study,” J. Biomed. Opt. 9(4), 828–834 (2004).

[17] V. V. Tuchin, E. A. Genina, A. N. Bashkatov, G. V. Simonenko, O. D. Odoevskaya, G. B. Altshuler, “A pilot study of ICG laser therapy of acne vulgaris: Photodynamic and photothermolysis treatment,” Lasers Surg. Med. 33(5), 296–310 (2003).

[18] G. B. Altshuler, M. Smirnov, I. Yaroslavsky, “Lattice of optical islets: A novel treatment modality in photomedicine,” J. Phys. D 38, 2732–2747 (2005).

[19] F. L. Pariser, P. F. Murray, “Intralesional injections of triamcinolone,” Arch. Dermatol. 87, 183– 187 (1963).

[20] E. A. Genina, A. N. Bashkatov, Y. Sinichkin, V. I. Kochubey, N. A. Lakodina, G. B. Altshuler, V. V. Tuchin, “In vitro and in vivo study of dye diffusion into the human skin and hair follicles,” J. Biomed. Opt. 7(3), 471–477 (2002).

[21] J. Jiang, R. K. Wang, “Comparing the synergetic effects of oleic acid and dimethyl sulfoxide as vehicles for optical clearing of skin tissue in vitro,” Phys. Med. Biol. 49, 5283–5294 (2004).

[22] K. D. Peck, A.-H. Ghanem, W. I. Higuchi, “Hindered diffusion of polar molecules through and effective pore radii estimates of intact and ethanol treated human epidermal membrane,” Pharmaceutical Res. 11, 1306–1314 (1994).

[23] C. N. Burkhart, L. Gottwald, “Assessment of etiologic agents in acne pathogenesis,” Skinmed. 2(4), 222–228 (2003).

[24] J. Lademann, A. Rudolph, U. Jacobi, H.-J. Weigmann, H. Schaefer, W. Sterry, M. Meinke, “Influence of nonhomogeneous distribution of topically applied UV filters on sun protection factors,” J. Biomed. Opt. 9, 1358–1362 (2004).

[25] J.-Y. Fang,W.-R. Lee, S.-C. Shen, Y.-P. Fang, C.-H. Hu, “Enhancement of topical 5-aminolaevulinic acid delivery by erbium: YAG laser and microdermabrasion: A comparison with iontophoresis and electroporation,” Br. J. Dermatol. 151, 132–140 (2004).

[26] O. Stumpp, A. J. Welch, J. Neev, “Enhancement of transdermal skin clearing agent delivery using a 980 nm diode laser,” Lasers Surg. Med. 37, 278–285 (2005).

[27] A. K. Nugroho, G. L. Li, M. Danhof, J. A. Bouwstra, “Transdermal iontophoresis of rotigotine across human stratum corneum in vitro: Influence of pH and NaCl concentration,” Pharmaceutical Res. 21(5), 844–850 (2004).

[28] H. Schaefer, T. E. Redelmeier, Skin Barrier: Principles of Percutaneous Absorption, Karger, Basel et al. (1996).

[29] S. Lee, D. J. McAuliffe, N. Kollias, T. J. Flotte, A. G. Doukas, “Photomechanical delivery of 100-nm microspheres through the stratum corneum: Implications for transdermal drug delivery,” Laser Surg. Med. 31, 207–210 (2002).

[30] O. Stumpp, A. J. Welch, “Injection of glycerol into porcine skin for optical skin clearing with needle-free injection gun and determination of agent distribution using OCT and fluorescence microscopy,” Proc. SPIE 4949, 44–50 (2003).

[31] E. A. Genina, A. N. Bashkatov, A. A. Korobko, E. A. Zubkova, V. V. Tuchin, I. V. Yaroslavsky, G. B. Altshuler, “Optical clearing of human skin: Comparative study of permeability and dehydration of intact and photothermally perforated skin,” J. Biomed. Opt. 13(2), 021102 (2008).